Donate Now
  • What We've Learned
Patient Decision Aids – Using them to Optimize Early Treatment in those with Rheumatoid Arthritis
pexels-photo-1181481_conversation_planning
Scientific Study Title:
Optimizing Early Treatment Strategies in Early Rheumatoid Arthritis through Shared Decision-Making
Start Date:
  • 2019
End Date:
  • 2021
Research Category
Tags

Why did we do this research?

Initially, when patients receive a diagnosis of a chronic disease, such as rheumatoid arthritis, they may feel overwhelmed and find it difficult to make decisions about treatment at the first rheumatology appointment. Patient decision aids are standardized tools that can help patients and their doctors discuss treatment options, leading to shared decision making. Many studies over the last 20 years have highlighted the benefits of decision aids in healthcare. We didn’t always have a good understanding of the best way to use these tools in clinic appointments. In this study, we used a decision aid that we have already developed and tested to help patients newly diagnosed with rheumatoid arthritis make decisions about their treatment. Our focus was to understand the best way to use this tool in the clinic.

What did we do?

This research included 2 phases:

  • Phase 1 included interviews with Canadian healthcare providers and patients with rheumatoid arthritis. We wanted to get their views on patient decision aids and explore the challenges and supports of using them.
  • Phase 2 included using a behaviour change model called the COM-B (Capability, Opportunity, Motivation, and Behavior) framework to help understand why people do or don't use decision aids. Mapping of the themes onto the COM-B framework was reviewed by patient partners and researchers and was also used to guide suggestions for how to encourage the use of decision aids on a national scale.
  • What Did We Find?

Fifteen health care providers and fifteen patients took part in the interviews. From their responses, five key themes were identified:

  • Decision making: Many health care providers tend to make decisions for rheumatoid arthritis patients without involving them much.
  • Patient needs: Patients want emotional support and educational tools to help them take part in making decisions about their treatment.
  • Implementation feasibility: There are many practical challenges to using decision aids in current arthritis-related healthcare systems.
  • Flexibility: Being flexible in how decision aids are implemented is important for success.
  • Health care provider training: Many health care providers are not very interested in getting more training on using decision aids.

Once the themes were mapped onto the COM-B framework, six recommendations were identified by the researchers and patient partners to increase the use of decision aids:

  • Make decision aids easily accessible to patients and provide education on shared decision-making via websites, social media, etc.
  • Develop an education curriculum for rheumatologists on shared decision making.
  • Use decision coaches or patient partners to support patients.
  • Connect decision aids with up-to-date rheumatoid arthritis guidelines.
  • Include shared decision making through the use of decision aids as a normalized standard of care.
  • Conduct trials to see how using decision aids and shared decision-making affects patients.
  • This research revealed the challenges and helped to identify proposed steps for implementing decision aid use in rheumatoid arthritis care in Canada.

The Research Team

Co-Principal Investigators

  • Claire Barber, MD, PhD, FRCPC, Research Scientist, Rheumatology, Arthritis Research Canada (University of Calgary)
  • Glen Hazlewood, MD, PhD, FRCPC, Research Scientist, Rheumatology, Arthritis Research Canada (University of Calgary)

Co-Investigators

  • Nick Bansback, MSc, PhD, Research Scientist, Health
  • Economics, Arthritis Research Canada (University of British Columbia)
  • Linda Li, BSc(PT), MSc, PhD, FCAHS, Senior Scientist, Arthritis Research Canada (University of British Columbia)
  • Dianne Mosher, MD, FRCPC (University of Calgary)

Research Staff

  • Victoria Bohm, MSc, MPH (University of Calgary)

Collaborators

  • Laurie Proulx, BComm, Vice President, Canadian Arthritis Patient Alliance
  • Dawn Richards, PhD, Vice President, Canadian Arthritis Patient Alliance

Who Funded This Research?

Canadian Initiative for Outcomes in Rheumatology cAre (CIORA)

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More